問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
施怡賢
下載
2025-02-01 - 2025-08-05
Condition/Disease
The study aimed to evaluate the efficacy of SAR444656 compared to placebo in treating AD lesions in adult subjects with moderate to severe AD. • Percentage change in EASI from baseline to week 16.
Test Drug
SAR444656
Participate Sites4Sites
Recruiting4Sites
2025-03-01 - 2027-12-31
Participate Sites3Sites
Recruiting3Sites
2024-09-15 - 2026-12-31
2025-10-01 - 2028-04-30
Participate Sites5Sites
Recruiting5Sites
2024-01-01 - 2025-09-10
Participate Sites9Sites
Recruiting7Sites
Terminated2Sites
2024-12-01 - 2027-11-30
Participate Sites10Sites
Recruiting10Sites
2025-08-01 - 2027-04-09
Participate Sites6Sites
Recruiting6Sites
2021-11-01 - 2025-12-31
Recruiting8Sites
Terminated1Sites
2024-01-01 - 2027-05-31
Not yet recruiting2Sites
2023-07-01 - 2029-08-10
全部
